Duration of remission ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Pain · patients with acute and subacute neck pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute and subacute neck pain Intermediate‐term · patients with acute and subacute neck pain
Manipulation (cervical) showed no clear difference in acute and subacute neck pain Intermediate‐term compared with oral medicine (moderate certainty).
1 finding from 1 review
Acute and subacute neck pain Long‐term · patients with acute and subacute neck pain
Manipulation (cervical) showed no clear difference in acute and subacute neck pain Long‐term compared with oral medicine (moderate certainty).
1 finding from 1 review
Function · patients with acute and subacute neck pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant satisfaction · patients with acute and subacute neck pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · patients with acute and subacute neck pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Although a higher percentage of people in the ATL and aCCT groups fell within Class I (seizure free) and Class II (> 50% reduction in seizures), no significant differences in seizure frequency were noted between the groups at 2 years after surgery... · people with temporal lobe epilepsy and intellectual disabilities
1 finding from 1 review
Maternal mortality Clinical assessment · women with postpartum iron deficiency anaemia
Intravenous iron showed no clear difference in maternal mortality Clinical assessment compared with oral iron (low certainty).
1 finding from 1 review
Fatigue · women with postpartum iron deficiency anaemia
1 finding from 1 review
Persistent anaemia symptoms ‐ not reported · women with postpartum iron deficiency anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Infections Clinical assessment · women with postpartum iron deficiency anaemia
It is very uncertain whether intravenous iron changes infections Clinical assessment compared with oral iron (very low certainty).
1 finding from 1 review
Constipation · women with postpartum iron deficiency anaemia
It is very uncertain whether intravenous iron changes constipation Reported by the women compared with oral iron (very low certainty).
1 finding from 1 review
All gastrointestinal symptoms Reported by the women · women with postpartum iron deficiency anaemia
It is very uncertain whether intravenous iron changes all gastrointestinal symptoms Reported by the women compared with oral iron (very low certainty).
1 finding from 1 review
Anaphylaxis or evidence of hypersensitivity Clinical assessment · women with postpartum iron deficiency anaemia
Intravenous iron showed no clear difference in anaphylaxis or evidence of hypersensitivity Clinical assessment compared with oral iron (low certainty).
1 finding from 1 review
Mortality after discharge (1‐3 months) · exacerbations of COPD
Treatment route: intravenous corticosteroid showed no clear difference in mortality after discharge (1‐3 months) compared with oral corticosteroid (moderate certainty).
1 finding from 1 review
Length of hospitalisation (days) · exacerbations of COPD
1 finding from 1 review
Adverse drug effect—hyperglycaemia · exacerbations of COPD
Treatment route: intravenous corticosteroid probably leads to higher adverse drug effect ‐ hyperglycaemia compared with oral corticosteroid (moderate certainty).
1 finding from 1 review
Arterial blood gas tension: PaO2 after 3 months mmHg · exacerbations of COPD
1 finding from 1 review
Treatment failure Need for additional treatment · exacerbations of COPD
Treatment route: intravenous corticosteroid showed no clear difference in treatment failure Need to intensify therapy compared with oral corticosteroid (moderate certainty).
1 finding from 1 review